Table 1.
Patient and tumor characteristics (N = 98)
| Age (years)a | 66 (8.2) |
| Gender (N; %) | |
| Male | 77 (78.6 %) |
| Female | 21 (21.4 %) |
| ASA classification (N; %) | |
| 1–2 | 64 (65.3 %) |
| 3 | 33 (33.7 %) |
| ECOG status (N; %) | |
| 0 | 74 (75.5 %) |
| 1–2 | 24 (24.5 %) |
| BMIa | 24.7 (3.8) |
| Neoadjuvant treatment (N; %) | 65 (66.3 %) |
| Chemotherapy | 16 (16.3 %) |
| Chemoradiotherapy | 49 (50.0 %) |
| Tumor histology (N; %) | |
| Adenocarcinoma | 79 (80.6 %) |
| Squamous cell carcinoma | 19 (19.4 %) |
| Clinical stage (N; %)b | |
| I | 19 (19.4 %) |
| IIA-B | 16 (16.3 %) |
| III | 44 (45.9 %) |
| IVA-B | 17 (17.4 %) |
| Not specified | 1 (1.0 %) |
| pN positive (N; %) | 35 (35.7 %) |
| Surgical technique (N; %) | |
| Ivor Lewis | 59 (60.2 %) |
| McKeown | 39 (39.8 %) |
| Prone position (N; %) | 46 (46.9 %) |
aMean (SD)
bAccording to AJCC 8th edition Classification
BMI, body mass index (kg/m2); ASA, American Society of Anesthesiologists physical status classification; ECOG, Eastern Cooperative Oncology Group Performance Status